NRXP

Beyond's analysis on NRXP

• 2026-09-11 — NRx Pharmaceuticals' subsidiary initiates deployment of FDA-cleared robotic TMS technology through HOPE Therapeutics

Recent news mentioning NRXP

• 2026-09-11 — NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Begins Training and Deployment of Zeta Surgical's FDA-Cleared Robotic TMS System
• 2026-08-07 — NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) to Host Conference Call August 10 to Discuss FDA First-Cycle ANDA Review and Commercial Plans

Appears alongside

• Nasdaq
• HOPE
• TMS

Browse the full archive →